jRCT1030230268Recruiting
Untitled Trial
Influence of dosing interval on immune related adverse events and infusion reaction of nivolumab and pembrolizumab
Japan Registry Clinical Trial
VerifiedJapan Registry Clinical Trial
Study focus
- Disease/Condition
- Neoplasms
- Study type
- Observational
Sponsor & location
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
ICD-10 classifications
NeoplasmsIn situ neoplasmsPersonal history of other neoplasmsBenign neoplasmsMalignant neoplasms
Data source
- Registry
- Japan Registry Clinical Trial
- Trial ID
- jRCT1030230268
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for jRCT1030230268 through Pure Global AI's free database. This phase not specified trial is sponsored by sponsor not specified and is currently Recruiting. The study focuses on Neoplasms.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.